3730
L. Ma et al. / Tetrahedron: Asymmetry 16 (2005) 3718–3734
(m, 2H, ArH); 13C NMR (75.5 MHz, CDCl3): d 21.6,
46.5, 50.2, 123.0, 127.6, 128.8, 128.9, 129.1, 129.6,
131.8, 132.0, 134.2, 135.8, 136.3, 144.6, 190.0; MS (EI)
m/z (rel. intensity, %) 455 (M+, 15), 299 (M+ꢀTs, 12),
105(PhCO +, 100), 77 (Ph+, 31). Anal. Calcd for
C22H18BrNO3S: C, 57.90; H, 3.98; N, 3.07. Found: C,
57.89; H, 4.02; N, 2.92.
(d, J = 8.1 Hz, 2H, ArH), 8.08–8.13 (m, 2H, ArH); 13C
NMR (75.5 MHz, CDCl3): 21.6, 47.2, 50.2,
d
115.9, 116.2, 127.4, 127.7, 128.6, 128.9, 129.5, 131.7,
131.8, 132.9, 136.5, 144.5, 188.8; MS (EI) m/z (rel. inten-
sity, %): 395(M +, 19), 240 (M+ꢀTs, 100), 155 (Ts+, 21),
123 (4-FC6H4CO+, 100). Anal. Calcd for C22H18FNO3S:
C, 66.82; H, 4.59; N, 3.54. Found: C, 66.70; H, 4.61;
N, 3.55.
4.3.4. (2S,3R)-2-Benzoyl-3-(4-methoxyphenyl)-1-(4-tolu-
enesulfonyl)aziridine 7g. Yellow crystals, yield 61%;
mp 43–45 ꢁC; Rf = 0.21 (ethyl acetate/petroleum ether
1:4, v/v, silica gel plate); 37% ee determined by HPLC
with chiral OD-H column with hexane/2-propanol
4.3.7. (2S,3R)-2-(4-Chlorobenzoyl)-3-phenyl-1-(4-toluene-
sulfonyl)aziridine 7m. Colorless crystals, yield 74%;
mp 145–147 ꢁC; Rf = 0.32 (ethyl acetate/petroleum ether
1:5, v/v, silica gel plate); 58% ee determined by HPLC
with Chiral OD-H column with hexane/2-propanol
(90:10, v/v) as an eluent at a flow rate of 0.7 mL/min
20
(sminor = 27.44 min; smajor = 35.07 min); ½a ¼ þ23:8
(90:10, v/v) as an eluent at a flow rate of 0.5mL/min
(c 0.98, CHCl3, 37% ee); IR (KBr) m (cmꢀ1)D: 1694 (s),
(smajor = 46.79 min; sminor = 51.26 min); ½a ¼ þ10:6
20
D
1
1329 (s), 1162 (s); H NMR (300 MHz, CDCl3): 2.42
(c 1.01, CHCl3, 58% ee); IR (KBr) m (cmꢀ1): 1687 (s),
1
(s, 3H, CH3), 3.67 (s, 3H, CH3), 4.33 (d, J = 7.5Hz,
1H, CH), 4.38 (d, J = 7.5Hz, 1H, CH), 6.67–6.70 (m,
2H, ArH), 7.14–7.17 (m, 2H, ArH), 7.33–7.41 (m, 4H,
ArH), 7.50–7.53 (m, 1H, ArH), 7.84–7.87 (m, 2H,
ArH), 7.95–7.98 (m, 2H, ArH); 13C NMR (75.5 MHz,
CDCl3): d 21.7, 46.3, 48.3, 55.1, 113.7, 123.1, 128.0,
128.3, 128.5, 128.7, 129.8, 133.8, 134.4, 135.6, 145.0,
159.6, 189.1; MS (EI) m/z (rel. intensity, %): 407 (M+,
6), 251 (M+ꢀTsꢀH, 100), 236 (M+ꢀTsꢀHꢀCH3, 18),
105(PhCO +, 27), 77 (Ph+, 32). Anal. Calcd for
C23H21NO4S: C, 67.79; H, 5.19; N, 3.44. Found: C,
67.75; H, 5.11; N, 3.13.
1330 (s), 1161 (s); H NMR (300 MHz, CDCl3): 2.41
(s, 3H, CH3), 4.18 (d, J = 4.0 Hz, 1H, CH), 4.52 (d,
J = 4.4 Hz, 1H, CH), 7.24 (d, J = 8.2 Hz, 2H, CH),
7.33 (s, 5H, ArH), 7.45 (d, J = 8.8 Hz, 2H, ArH), 7.71
(d, J = 8.2 Hz, 2H, ArH), 8.00 (d, J = 8.4 Hz, 2H,
ArH); 13C NMR (75.5 MHz, CDCl3): d 21.6, 47.2,
50.3, 127.3, 127.7, 128.7, 128.9, 129.1, 129.5, 130.3,
132.8, 134.3, 136.3, 140.7, 144.6, 189.2; MS (EI) m/z
(rel. intensity, %): 411 (M+, 5), 255 (M+ꢀTsꢀH, 100),
139 (ClC6H4CO+, 71), 111 (C1C6Hþ, 35), 77 (Ph+,
4
24). Anal. Calcd for C22H18ClNO3S: C, 64.15; H, 4.40;
N, 3.40. Found: C, 64.10; H, 4.53; N, 3.12.
4.3.5. (2S,3R)-2-Benzoyl-3-(2-methoxyphenyl)-1-(4-tolu-
enesulfonyl)aziridine 7h. Colorless crystals, yield 21%;
mp 143–145 ꢁC; Rf = 0.24 (ethyl acetate/petroleum ether
1:5, v/v, silica gel plate); 27% ee determined by HPLC
with chiral OD-H column with hexane/2-propanol
4.3.8. (2S,3R)-2-(4-Bromobenzoyl)-3-phenyl-1-(4-toluene-
sulfonyl)aziridine 7n. Colorless needle crystals, yield
64%; mp 143–145 ꢁC; Rf = 0.32 (ethyl acetate/petroleum
ether 1:6, v/v, silica gel plate); 50% ee determined by
HPLC with chiral OD-H column with hexane/2-propa-
(90:10, v/v) as an eluent at a flow rate of 0.8 mL/min
nol (93:7, v/v) as an eluent at a flow rate of 0.8 mL/min
20
20
(smajor = 27.29 min; sminor = 32.05min); ½a ¼ ꢀ13:6
(smajor = 36.2 min; sminor = 39.7 min); ½a ¼ þ10:8 (c
D
D
(c 0.45, CHCl3, 27% ee); IR (KBr) m (cmꢀ1): 1693 (s),
1.00, CHCl3, 50% ee); IR (KBr) m (cmꢀ1): 1688 (s),
1
1
1328 (s), 1162 (s); H NMR (300 MHz, CDCl3): 2.41
1329 (s), 1160 (s); H NMR (300 MHz, CDCl3): 2.41
(s, 3H, CH3), 3.73 (s, 3H, CH3), 4.41 (d, J = 4.5Hz,
1H, CH), 4.64 (d, J = 4.5Hz, 1H, CH), 6.84–6.92 (m,
2H, ArH), 7.20–7.34 (m, 4H, ArH), 7.48–7.51 (m, 2H,
ArH), 7.61–7.64 (m, 1H, ArH), 7.72–7.74 (m,
2H, ArH), 8.09–8.13 (m, 2H, ArH); 13C NMR (75.5
MHz, CDCl3): d 21.6, 44.9, 48.2, 55.2, 110.3, 120.3,
120.7, 127.8, 128.0, 128.7, 128.9, 129.3, 130.1, 133.9,
136.0, 136.6, 144.1, 158.8, 190.9; MS (EI) m/z (rel. inten-
sity, %): 407 (M+, 28), 376 (M+ꢀOMe, 4.5), 252
(M+ꢀTs, 20), 155 (Ts+, 3.3), 105(PhCO +, 100), 77
(Ph+, 8.9). Anal. Calcd for C23H21NO4S: C, 67.79; H,
5.19; N, 3.44. Found: C, 67.87; H, 5.11; N, 3.13.
(s, 3H, CH3), 4.17 (d, J = 4.2 Hz, 1H, CH), 4.52 (d,
J = 4.2 Hz, 1H, CH), 7.22–7.33 (m, 7H, ArH), 7.62 (d,
J = 8.7 Hz, 2H, ArH), 7.70 (d, J = 8.4 Hz, 2H, ArH),
7.91 (d, J = 8.7 Hz, 2H, ArH),; 13C NMR (75.5 MHz,
CDCl3): d 21.6, 47.1, 50.2, 126.4, 127.3, 127.7, 128.6,
128.9, 129.5, 130.3, 132.1, 132.8, 134.6, 136.3, 144.5,
189.4; MS (EI) m/z (rel. intensity, %): 455 (M+, 22),
300 (M+ꢀTs, 7.8), 185(95), 183 (4-BrC 6H4CO+, 100),
155 (Ts+, 39). Anal. Calcd for C22H18BrNO3S: C,
57.90; H, 3.98; N, 3.07. Found: C, 57.85; H, 4.09; N,
3.06.
4.3.9. (2S,3R)-2-(4-Nitrobenzoyl)-3-phenyl-1-(4-toluene-
sulfonyl)aziridine 7o. Colorless needle crystals, yield
61%; mp 146–148 ꢁC; Rf = 0.28 (ethyl acetate/petroleum
4.3.6. (2S,3R)-2-(4-Fluorobenzoyl)-3-phenyl-1-(4-toluene-
sulfonyl)aziridine 7l. Colorless needle crystals, yield
72%; mp 123.5–125.5 ꢁC; Rf = 0.34 (ethyl acetate/petro-
leum ether 1:5, v/v, silica gel plate); 54% ee determined
by HPLC with chiral OD-H column with hexane/2-pro-
ether 1:6, v/v, silica gel plate); The ee value cannot be
25
determined due to very poor solubility; ½a ¼ þ6:3 (c
D
0.73, CHCl3); IR (KBr) m (cmꢀ1): 1697 (s), 1335(s),
1159 (s); 1H NMR (300 MHz, CDCl3): 2.42 (s, 3H,
CH3), 4.17 (d, J = 4.2 Hz, 1H, CH), 4.58 (d,
J = 4.2 Hz, 1H, CH), 7.25–7.35 (m, 7H, ArH), 7.72 (d,
J = 8.4 Hz, 2H, ArH), 8.23 (d, J = 9.0 Hz, 2H, ArH),
8.34 (d, J = 9.0 Hz, 2H, ArH); 13C NMR (50 MHz,
CDCl3): d 21.6, 47.2, 50.5, 123.9, 127.2, 127.7, 128.8,
panol (94:6, v/v) as an eluent at a flow rate of 0.8 mL/
25
min (smajor = 35.06 min; sminor = 38.21 min); ½a ¼ þ7:9
D
(c 0.68, CHCl3, 54% ee); IR (KBr) m (cmꢀ1): 1687 (s),
1
1333 (s), 1160 (s); H NMR (300 MHz, CDCl3): 2.41
(s, 3H, CH3), 4.20 (d, J = 4.2 Hz, 1H, CH), 4.52 (d,
J = 4.2 Hz, 1H, CH), 7.13–7.33 (m, 9H, ArH), 7.72